ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 37 of 53

Hyperthyroidism 38 Examples Hydronephrosis Preauricular sinus and/or cyst Propylthiouracil b Face and neck Urinary system Respiratory system Circulatory system Digestive system Integumentary system Odds ratio 0.1 0.2 0.4 1 2 4 8 12 20 First Trimester ATD Exposure and Congenital Malformation Risks Figure 6. Risks of Antithyroid Drugs During Pregnancy Prevalence of congenital malformations Unexposed ATD group PTU use only 5.9% (N=170,716/2,872,109) Within 1 year of birth a 7.0% (N=699/9,930) 5.7% (N=45,982/811,730) Within 2 years of birth b 8.0% (N=45/564) a Seo GH, et al. Ann Intern Med 2018;168(6):405–413 b Andersen SL, et al. J Clin Endocrinol Metab 2019;104(2):6040–6048

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum